Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: SC Liver Research Consortium, LLC
Condition: Hepatocellular Carcinoma
NCT04476329
Optimization for Regorafenib in HCC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Enrollment rate not sufficient to meet funding entity's corporation timeline expectations, entity terminated study's fiscal support. Termination decision was purely administrative in nature and did not involve drug or patient safety issues.